- Generic name
- Levetiracetam
- Strength
- 100 mg/ml
- Dosage form
- Suspension
- Manufactured by
- Renata PLC.
Epicet Oral Solution Suspension
About Epicet Oral Solution 100 mg/ml Suspension
Epicet Oral Solution is a suspension medicine that contains levetiracetam, an adjunct anti-epileptic drug. It is used in epilepsy treatment as part of a plan set by the doctor.
There are 34 brands of Levetiracetam listed in Bangladesh. The lowest listed price is Citazar 250 mg Tablet at ৳ 15.11 per unit.
What is Epicet Oral Solution 100 mg/ml Suspension?
Epicet Oral Solution is an oral suspension from Renata PLC. that contains levetiracetam at a strength of 100 mg/ml. Levetiracetam belongs to the group of adjunct anti-epileptic drugs, which are medicines used alongside other treatment in epilepsy care. It is used for certain types of seizures, and the doctor decides whether it suits a particular person. Because it is a liquid, it may be chosen when a suspension form is preferred. The doctor or pharmacist can explain how it fits into an individual treatment plan. Do not start, change or stop it without medical advice.
Uses of Epicet Oral Solution
Epicet Oral Solution is used in the treatment of epilepsy. Levetiracetam, the active ingredient, is an adjunct anti-epileptic drug, meaning it is often used together with other epilepsy medicines. It is prescribed for certain seizure types; the doctor decides which seizures it is suitable for and whether it is given alone or with other medicines. If you are unsure why it has been prescribed, ask the doctor or pharmacist to explain.
How to use Epicet Oral Solution
Epicet Oral Solution is a suspension that is swallowed. The doctor decides the dose and how long it should be taken, and this is set for each person. Follow the instructions given by the doctor or pharmacist exactly, and do not change the amount or stop the medicine on your own. If a dose is missed or you are unsure about anything, ask the doctor or pharmacist for guidance rather than guessing.
Side effects of Epicet Oral Solution
Some people may notice side effects while taking levetiracetam. In adults, commonly reported effects include sleepiness, weakness, infection and dizziness. In children, fatigue, aggression, nasal congestion, decreased appetite and irritability have been commonly reported. Contact the doctor if a side effect bothers you or does not settle. Seek medical help promptly if you notice serious or unexpected symptoms, or if the person becomes very unwell.
Safety and precautions
Tell the doctor before use if there is an allergy to levetiracetam, other pyrrolidone derivatives or any ingredient of the suspension. Levetiracetam is not recommended during pregnancy, and women who could become pregnant should discuss contraception with the doctor; it is also not recommended during breastfeeding unless the doctor decides it is needed. People with kidney or liver problems may need extra checks, and blood cell counts have rarely been affected. Ask the doctor first about any health concern, other medicines or suitability.
Frequently asked questions
What is Epicet Oral Solution used for and what kind of medicine is it?
It is an adjunct anti-epileptic medicine containing levetiracetam, used in the treatment of epilepsy. It is a suspension taken by mouth. The doctor decides which seizure types it is suitable for and whether it is used with other epilepsy medicines.
How should Epicet Oral Solution be taken?
It is swallowed as a suspension. The doctor decides the dose and how long it should be taken, so follow their instructions exactly. Do not change the amount or stop it on your own. Ask the doctor or pharmacist if anything is unclear.
What side effects should I watch for?
Adults may notice sleepiness, weakness, infection or dizziness. Children may have fatigue, aggression, nasal congestion, decreased appetite or irritability. Tell the doctor if a side effect bothers you or does not settle, and get help promptly if the person becomes very unwell.
Who should check with a doctor before using it?
Anyone with an allergy to levetiracetam or related ingredients, people with kidney or liver problems, and women who are pregnant, could become pregnant or are breastfeeding should speak to the doctor first. The doctor will decide whether it is suitable.
Indications
- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. ... Read more
- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy.
- in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
- in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Dosage & Administration
Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.
Pediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used.
- Monotherapy: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.
- Add-on therapy: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults.
- Add-on therapy: For infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.
Interaction
Probenecid: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite but not of levetiracetam. Nevertheless, the concentration of this metabolite remains low.
Methotrexate: Concomitant administration of levetiracetam and methotrexate has been reported to decrease methotrexate clearance, resulting in increased/prolonged blood methotrexate concentration to potentially toxic levels. Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs.
Laxatives: There have been isolated reports of decreased levetiracetam efficacy when the osmotic laxative macrogol has been concomitantly administered with oral levetiracetam. Therefore, macrogol should not be taken orally for one hour before and for one hour after taking levetiracetam.
Food and alcohol: The extent of absorption of levetiracetam was not altered by food, but the rate of absorption was slightly reduced. No data on the interaction of levetiracetam with alcohol are available.
Contraindications
Side Effects
- Adult patients: somnolence, asthenia, infection and dizziness
- Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability
Pregnancy & Lactation
Precautions & Warnings
Acute kidney injury: The use of levetiracetam has been very rarely associated with acute kidney injury with a time to onset ranging from a few days to several months.
Blood cell counts: Rare cases of decreased blood cell counts (neutropenia, agranulocytosis, leucopenia, thrombocytopenia and pancytopenia) have been described in association with levetiracetam administration, generally at the beginning of the treatment. Complete blood cell counts are advised in patients experiencing important weakness, pyrexia, recurrent infections or coagulation disorders.
Suicide: Suicide, suicide attempt, suicidal ideation and behaviour have been reported in patients treated with anti-epileptic agents (including levetiracetam). A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour. The mechanism of this risk is not known. Therefore patients should be monitored for signs of depression and/or suicidal ideation and behaviours and appropriate treatment should be considered. Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/or suicidal ideation or behaviour emerge.
Paediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Available data in children did not suggest an impact on growth and puberty. However, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.
Overdose Effects
Storage Conditions
Alternative brands of Levetiracetam
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.